Atria Wealth Solutions, Inc. Edwards Lifesciences Corp Transaction History

Atria Wealth Solutions, Inc.

$4.15 Billion
Q2 2025

A detailed history of Atria Wealth Solutions, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 3,443 shares of EW stock, worth $260,772. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,443

Previous 6,662 48.32%

Holding current value

$260,772

Previous $482,000 44.19%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	SELL	$67.07 - $78.22 $215,898 - $251,790	-3,219 Reduced 48.32%	3,443 $269,000
Q1 2025 May 09, 2025	SELL	$67.95 - $76.19 $2.02 Million - $2.27 Million	-29,763 Reduced 81.71%	6,662 $482,000
Q4 2024 Jan 31, 2025	SELL	$64.54 - $75.92 $20,717 - $24,370	-321 Reduced 0.87%	36,425 $2.7 Million
Q3 2024 Nov 08, 2024	SELL	$59.7 - $93.78 $601,298 - $944,552	-10,072 Reduced 21.51%	36,746 $2.42 Million
Q2 2024 Jul 22, 2024	BUY	$84.3 - $94.31 $79,157 - $88,557	939 Added 2.05%	46,818 $4.32 Million
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $62,602 - $82,468	863 Added 1.92%	45,879 $4.38 Million
Q4 2023 Feb 02, 2024	SELL	$61.71 - $77.76 $5,677 - $7,153	-92 Reduced 0.2%	45,016 $3.43 Million
Q3 2023 Nov 08, 2023	SELL	$69.28 - $93.38 $166,618 - $224,578	-2,405 Reduced 5.06%	45,108 $3.13 Million
Q2 2023 Aug 03, 2023	SELL	$81.41 - $94.33 $1.06 Million - $1.23 Million	-13,019 Reduced 21.51%	47,513 $4.48 Million
Q1 2023 Aug 22, 2023	BUY	$74.26 - $84.51 $893,570 - $1.02 Million	12,033 Added 25.33%	59,546 $4.93 Million
Q1 2023 Jun 14, 2023	BUY	$74.26 - $84.51 $73,220 - $83,326	986 Added 1.66%	60,532 $5.01 Million
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $251,147 - $285,812	-3,382 Reduced 5.37%	59,546 $4.93 Million
Q4 2022 Aug 30, 2023	BUY	$68.3 - $87.44 $889,197 - $1.14 Million	13,019 Added 27.4%	60,532 $4.52 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $77,315 - $98,982	-1,132 Reduced 1.77%	62,928 $4.7 Million
Q3 2022 Feb 13, 2023	SELL	$82.37 - $107.29 $393,234 - $512,202	-4,774 Reduced 6.94%	64,060 $5.29 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.95 Million - $2.54 Million	23,667 Added 52.4%	68,834 $5.87 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $648,750 - $962,025	7,500 Added 19.91%	45,167 $4.3 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $3.84 Million - $4.83 Million	37,667 New	37,667 $4.43 Million

Others Institutions Holding EW

# of Institutions

1,445

Shares Held

484M

Call Options Held

2.76M

Put Options Held

1.54M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.

Account

Atria Wealth Solutions, Inc. Edwards Lifesciences Corp Transaction History